CIAM
NAUT icon

Caitong International Asset Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Caitong International Asset Management’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223 Buy
119
+118
+11,800% +$312 ﹤0.01% 1977
2026
Q1 		$4 Buy
+1
New +$2 ﹤0.01% 2336

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Caitong International Asset Management's NAUT Position: Q2 2026 in Review

Caitong International Asset Management increased its Nautilus Biotechnolgy (NAUT) stake by 11,800% in Q2 2026, buying an estimated $312 and bringing the position to 119 shares worth $223. The position accounts for ﹤0.01% of the portfolio, ranked #1977.

Caitong International Asset Management first reported a position in NAUT in Q1 2026 and has held it in 2 quarters since. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Caitong International Asset Management held 119 shares of Nautilus Biotechnolgy worth $223 as of Q2 2026.
  • Caitong International Asset Management bought 118 Nautilus Biotechnolgy shares in Q2 2026, an estimated $312.
  • Nautilus Biotechnolgy made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1977 holding.
  • Caitong International Asset Management first reported a position in Nautilus Biotechnolgy in Q1 2026 and has held it in 2 quarters since.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.